Evidence map›Paper›PMID 26666913›Full record

ArticleThe Journal of general physiology2016

R4496C RyR2 mutation impairs atrial and ventricular contractility.

Cecilia Ferrantini, Raffaele Coppini, Beatrice Scellini, Claudia Ferrara, Josè Manuel Pioner, Luca Mazzoni, Silvia Priori, Elisabetta Cerbai, Chiara Tesi, Corrado Poggesi

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Differences in Effects of Length-Dependent Regulation of Force and CaInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Effect of Myosin Isoforms on Cardiac Muscle Twitch of Mice, Rats and Humans.International journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
  9. Alpha and beta myosin isoforms and human atrial and ventricular contraction.Cellular and molecular life sciences : CMLS · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Cecilia FerrantiniCenter for Molecular Medicine and Applied Biophysics, University of Florence, 50121 Florence, Italy cecilia.ferrantini@unifi.it.
Raffaele CoppiniCenter for Molecular Medicine and Applied Biophysics, University of Florence, 50121 Florence, Italy.
Beatrice ScelliniCenter for Molecular Medicine and Applied Biophysics, University of Florence, 50121 Florence, Italy.
Claudia FerraraCenter for Molecular Medicine and Applied Biophysics, University of Florence, 50121 Florence, Italy.
Josè Manuel PionerCenter for Molecular Medicine and Applied Biophysics, University of Florence, 50121 Florence, Italy.
Luca MazzoniCenter for Molecular Medicine and Applied Biophysics, University of Florence, 50121 Florence, Italy.
Silvia PrioriIRCCS Fondazione Salvatore Maugeri, 27100 Pavia, Italy.
Elisabetta CerbaiCenter for Molecular Medicine and Applied Biophysics, University of Florence, 50121 Florence, Italy.
Chiara TesiCenter for Molecular Medicine and Applied Biophysics, University of Florence, 50121 Florence, Italy.
Corrado PoggesiCenter for Molecular Medicine and Applied Biophysics, University of Florence, 50121 Florence, Italy.
University of Florence · ITFondazione Salvatore Maugeri · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ryanodine receptor (RyR2) is the major Ca(2+) channel of the cardiac sarcoplasmic reticulum (SR) and plays a crucial role in the generation of myocardial force. Changes in RyR2 gating properties and resulting increases in its open probability (Po) are associated with Ca(2+) leakage from the SR and arrhythmias; however, the effects of RyR2 dysfunction on myocardial contractility are unknown. Here, we investigated the possibility that a RyR2 mutation associated with catecholaminergic polymorphic ventricular tachycardia, R4496C, affects the contractile function of atrial and ventricular myocardium. We measured isometric twitch tension in left ventricular and atrial trabeculae from wild-type mice and heterozygous transgenic mice carrying the R4496C RyR2 mutation and found that twitch force was comparable under baseline conditions (30°C, 2 mM [Ca(2+)]o, 1 Hz). However, the positive inotropic responses to high stimulation frequency, 0.1 µM isoproterenol, and 5 mM [Ca(2+)]o were decreased in R4496C trabeculae, as was post-rest potentiation. We investigated the mechanisms underlying inotropic insufficiency in R4496C muscles in single ventricular myocytes. Under baseline conditions, the amplitude of the Ca(2+) transient was normal, despite the reduced SR Ca(2+) content. Under inotropic challenge, however, R4496C myocytes were unable to boost the amplitude of Ca(2+) transients because they are incapable of properly increasing the amount of Ca(2+) stored in the SR because of a larger SR Ca(2+) leakage. Recovery of force in response to premature stimuli was faster in R4496C myocardium, despite the unchanged rates of recovery of L-type Ca(2+) channel current (ICa-L) and SR Ca(2+) content in single myocytes. A faster recovery from inactivation of the mutant R4496C channels could explain this behavior. In conclusion, changes in RyR2 channel gating associated with the R4496C mutation could be directly responsible for the alterations in both ventricular and atrial contractility. The increased RyR2 Po and fractional Ca(2+) release from the SR induced by the R4496C mutation preserves baseline contractility despite a slight decrease in SR Ca(2+) content, but cannot compensate for the inability to increase SR Ca(2+) content during inotropic challenge.

Indexed as

AnimalsArrhythmias, CardiacCalciumCalcium Channels, L-TypeCalcium SignalingHeart AtriaHeart VentriclesIsoproterenolMiceMice, Inbred C57BLMice, TransgenicMuscle ContractionMutationMyocytes, CardiacPolymorphic Catecholaminergic Ventricular TachycardiaRyanodine Receptor Calcium Release ChannelCalciumCalcium Channels, L-TypeIsoproterenolRyanodine Receptor Calcium Release Channel

Identifiers

PMID26666913
PMCPMC4692489
OpenAlexW2228278740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.